breast cancer

Using 23andMe Jessica learned she carries a BRCA1 variant that puts her at risk for breast or ovarian cancer a risk she wouldn't have learned of otherwise. Like many other women with a similar risk, she slipped through the cracks for traditional screening because she didn't meet the current criteria.

For Breast Cancer Awareness Month, we wanted to shed some light on something you might not know. Studies suggest that more than half of individuals with a cancer-related variant in...

October is Breast Cancer Awareness Month, a time to draw attention and support for the importance of early detection and treatment of this disease. As part of Breast Cancer Awareness...

23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.

23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report. The report covers three variants in the BRCA1 and BRCA2 genes associated with increased risk for breast, ovarian, and prostate cancer.

In the largest study of its kind researchers at the University of Cambridge have identified more than 380 genetic variants associated with the timing of puberty in men and women. The...

It’s been a perennial problem –biomedical research that largely leaves behind women and people with non-European ancestry. A newly published study by researchers at the University of California San Francisco...

Two new studies done by researchers in France and the United States connect the dots between the number of moles women have and their risk for developing breast cancer. Published...

By Anne Pinckard The high rates of type 2 diabetes in some minority communities as well as the rates for prostate cancer among African American men are a good illustration...

Angelina Jolie’s revelation in the New York Times today that she had a double mastectomy after learning about her genetic risk for breast cancer focused attention on the difficult dilemma...